Guardian Capital LP increased its holdings in Stryker Corporation (NYSE:SYK) by 4.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 124,492 shares of the medical technology company’s stock after buying an additional 4,849 shares during the quarter. Guardian Capital LP’s holdings in Stryker were worth $17,680,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. Acrospire Investment Management LLC purchased a new position in shares of Stryker in the second quarter worth approximately $111,000. Motco boosted its holdings in shares of Stryker by 50.7% in the second quarter. Motco now owns 826 shares of the medical technology company’s stock worth $115,000 after buying an additional 278 shares during the last quarter. San Francisco Sentry Investment Group CA boosted its holdings in shares of Stryker by 47.8% in the third quarter. San Francisco Sentry Investment Group CA now owns 1,005 shares of the medical technology company’s stock worth $143,000 after buying an additional 325 shares during the last quarter. Bruderman Asset Management LLC purchased a new position in shares of Stryker in the second quarter worth approximately $150,000. Finally, James Investment Research Inc. purchased a new position in shares of Stryker in the second quarter worth approximately $155,000. 74.97% of the stock is currently owned by institutional investors.
SYK has been the topic of a number of research reports. Piper Jaffray Companies reissued an “overweight” rating and issued a $148.00 price objective on shares of Stryker in a report on Thursday, August 24th. Needham & Company LLC raised shares of Stryker from an “underperform” rating to a “hold” rating in a report on Friday, August 25th. Robert W. Baird raised shares of Stryker from a “neutral” rating to an “outperform” rating and raised their price objective for the stock from $161.00 to $173.00 in a report on Thursday, November 16th. BidaskClub downgraded shares of Stryker from a “buy” rating to a “hold” rating in a report on Saturday, August 26th. Finally, ValuEngine raised shares of Stryker from a “hold” rating to a “buy” rating in a report on Tuesday, November 14th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and thirteen have given a buy rating to the company’s stock. Stryker currently has an average rating of “Hold” and a consensus price target of $153.19.
Stryker Corporation (SYK) traded up $0.78 during trading on Tuesday, hitting $152.71. 826,100 shares of the stock traded hands, compared to its average volume of 1,177,418. The company has a market capitalization of $56,857.92, a PE ratio of 24.08, a P/E/G ratio of 2.39 and a beta of 0.78. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.61 and a current ratio of 2.37. Stryker Corporation has a 52-week low of $116.27 and a 52-week high of $160.62.
Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, October 26th. The medical technology company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.50 by $0.02. The firm had revenue of $3.01 billion for the quarter, compared to analysts’ expectations of $2.97 billion. Stryker had a net margin of 14.67% and a return on equity of 24.11%. The company’s revenue for the quarter was up 6.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.39 earnings per share. sell-side analysts expect that Stryker Corporation will post 6.47 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 31st. Stockholders of record on Friday, December 29th will be given a dividend of $0.47 per share. The ex-dividend date is Thursday, December 28th. This represents a $1.88 annualized dividend and a dividend yield of 1.23%. This is a boost from Stryker’s previous quarterly dividend of $0.43. Stryker’s dividend payout ratio (DPR) is presently 36.32%.
In other news, insider Lonny J. Carpenter sold 5,000 shares of Stryker stock in a transaction that occurred on Friday, November 3rd. The shares were sold at an average price of $155.34, for a total transaction of $776,700.00. Following the sale, the insider now owns 83,207 shares in the company, valued at $12,925,375.38. The transaction was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 7.40% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This article was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this article on another website, it was stolen and republished in violation of international copyright laws. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2017/12/12/stryker-corporation-syk-shares-bought-by-guardian-capital-lp.html.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.